OncoTrace™ Recombinant Monoclonal Antibodies – EasyPath
The Future of Immunohistochemistry with Diagnostic Clarity
The recombinant monoclonal antibodies of the OncoTrace™ line, made exclusively by EasyPath, represent the new generation of reagents for immunohistochemical (IHQ) cancer diagnostics. Produced in vitro with bioengineering technology, they deliver stable performance, consistent results and greater reliability for pathologists seeking precision and reproducibility.
What are Recombinant Antibodies?
Recombinant antibodies are produced by genetic engineering in controlled systems, without the need for hybridomas or the use of animals. This guarantees standardization, purity and uniformity in each batch, reducing variations in laboratory results and increasing the quality of histopathological diagnosis.
Difference between Hybridoma Antibodies and Recombinant Monoclonal Antibodies

Aspect
Recombinant Monoclonal Antibodies (OncoTrace™)
Traditional Hybridoma Antibodies

Origin
Produced in vitro, without animal use
Derived from hybridomas in animal models

Consistency
Absolute batch-to-batch reproducibility
High variability between batches

Reactivity
Less cross-reactivity and non-specific background
Higher risk of false positives

Scalability
Unlimited, standardized production
Dependence on cell colonies

Benefits of the Recombinant Antibody in the IHQ Technique

Clean, clear staining with no nonspecific background
High sensitivity and specificity in cancer diagnosis
Stability and reliability in all batches
Reduction of false negatives and greater diagnostic clarity
Sustainable and animal cruelty-free production

Why Choose OncoTrace™ Recombinant Antibodies?
By opting for OncoTrace™ recombinant monoclonal antibodies, the laboratory ensures clearer, standardized and reproducible diagnoses. This innovation takes the practice of immunohistochemistry to a new level, reducing uncertainty and optimizing clinical decision-making in oncology.
What is the advantage for routine diagnostics?
Greater reliability, clarity in staining and absolute standardization, optimizing the pathologist’s time and reducing rework.
Transform your Diagnosis with OncoTrace™
The OncoTrace™ EasyPath line delivers the latest in recombinant monoclonal antibodies, combining innovation, reliability and cost-effectiveness.
Request a quote now and raise the quality of your immunohistochemistry.